ZULIP-GP1 TAB MANUFACTURERS SUPPLIERS - THIRD PARTY CONTRACT MANUFACTURING
COMPOSITION:GLIMEPRIDE 1MG, METFORMIN 500 MG & PIOGLITAZONE 15 MG
Glimepiride, Pioglitazone & Metformin Hydrochloride (ER) Tablets – A combination of three antidiabetic medicines, Glimepiride, Pioglitazone, and Metformin are used in the treatment of Type 2 diabetes mellitus. These medicines help in controlling blood sugar levels. Available with the brand name ZULIP-GP1, these tablets are manufactured and supplied by the Best Glimepiride, Pioglitazone & Metformin Hydrochloride Tablet Manufacturer, Arlak Biotech.
When one or dual therapy is ineffective, Glimepiride, Pioglitazone & Metformin work through various ways to provide better control of blood sugar levels.
Glimepiride is a sulfonylurea that works by lowering blood glucose by increasing the insulin amount that the pancreas releases.
Pioglitazone is a thiazolidinedione that acts by reducing the amount of glucose that the liver produces while making the tissues more sensitive to the actions of insulin.
Metformin is a biguanide that functions by reducing the liver’s ability to produce glucose, slowing the intestine’s ability to absorb glucose, and increasing the sensitivity of the body to insulin.
Medicinal treatment of Type 2 diabetes mellitus requires complete caution. Thus, while taking Glimepiride, Pioglitazone & Metformin Hydrochloride (ER) Tablets, keep the following general instructions in consideration:
Glimepiride, Pioglitazone & Metformin Hydrochloride (ER) Tablets should not be taken without consulting the doctor in the following health conditions:
Glimepiride, Pioglitazone & Metformin Hydrochloride (ER) Tablets may result in common side effects. These adverse effects can range from mild to moderate. Following are the common side effects associated with this medication:
In case you encounter any severity in these side effects or they don’t leave the body, consult the doctor.